Hound Partners’s Forte Biosciences FBRX Stock Holding History

Hound Partners’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-283	Closed	-$871K	–	31
2018 Q4	$871K	Buy	+283	New	+$1.22M	0.03%	24

Other funds holding FBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hound Partners's FBRX Position: Q1 2019 in Review

Hound Partners sold out of Forte Biosciences (FBRX) in Q1 2019, closing a stake of 283 shares — an estimated $871K sold.

Hound Partners first reported a position in FBRX in Q4 2018 and held it in 1 quarter. The position peaked at $871K in Q4 2018. 78 funds tracked by Wall St. Rank hold FBRX as of Q1 2019.

Hound Partners reported no remaining Forte Biosciences position as of Q1 2019 after selling out during the quarter.
Hound Partners sold 283 Forte Biosciences shares in Q1 2019, an estimated $871K.
Hound Partners first reported a position in Forte Biosciences in Q4 2018 and held it in 1 quarter.
Hound Partners's Forte Biosciences position peaked at $871K in Q4 2018.
78 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2019.

Based on Hound Partners's 13F filing for Q1 2019, filed 15 May 2019.